FDA expands approved use of drug to treat liver cancer
On April 27, the U.S. Food and Drug Administration (FDA) expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular…
Web Exclusives
FDA approves new combination treatment for acute myeloid leukemia
On April 28, the U.S. Food and Drug Administration (FDA) approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid…
CDC releases updated guideline for prevention of surgical site infection
The Centers for Disease Control (CDC) has updated its 1999 guideline for the prevention of surgical site infection. Read more
New international consensus statement on sport concussion released
The 2017 Concussion in Sport Group (CISG) consensus statement in British Journal of Sports Medicine emphasizes “recognize and remove.” Access the statement
Intranasal medications gain popularity in the ED
Administering medications intranasally as an alternative to I.V.s and injections is becoming more frequent in the ED and out-of-hospital settings, according to a study…
Local warming before tourniquet application increases vein size
Applying local warmth before a tourniquet significantly increases venodilation without adverse effects, according to a study in the International Journal of Nursing Studies. Read…
Passive leg-raising may help predict fluid responsiveness
Passive leg-raising helps predict response to fluid administration given to patients in shock, according to a study in Critical Care Nurse. Read more
FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. It’s the first drug…
Rise in chronic venous insufficiency procedures
The use of procedures to treat chronic venous insufficiency in Medicare patients increased markedly from 2005 through 2014, according to a study in Journal…
FDA approves hepatitis C drugs for pediatric patients
On April 7, the U.S. Food and Drug Administration (FDA) approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis…
FDA allows marketing of consumer genetic tests
On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR)…
Yoga may ease side effects of prostate cancer treatment
For men with prostate cancer, structured yoga class twice a week during radiation treatment reduces fatigue and urinary and sexual dysfunction, according to a…
FDA expands approved use of drug to treat liver cancer
On April 27, the U.S. Food and Drug Administration (FDA) expanded the approved use of Stivarga (regorafinib) to include treatment of patients…
FDA approves new combination treatment for acute myeloid leukemia
On April 28, the U.S. Food and Drug Administration (FDA) approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed…
CDC releases updated guideline for prevention of surgical site infection
The Centers for Disease Control (CDC) has updated its 1999 guideline for the prevention of surgical site infection. Read more
New international consensus statement on sport concussion released
The 2017 Concussion in Sport Group (CISG) consensus statement in British Journal of Sports Medicine emphasizes “recognize and remove.” Access the statement
Intranasal medications gain popularity in the ED
Administering medications intranasally as an alternative to I.V.s and injections is becoming more frequent in the ED and out-of-hospital settings, according to…
Local warming before tourniquet application increases vein size
Applying local warmth before a tourniquet significantly increases venodilation without adverse effects, according to a study in the International Journal of Nursing…
Passive leg-raising may help predict fluid responsiveness
Passive leg-raising helps predict response to fluid administration given to patients in shock, according to a study in Critical Care Nurse. Read…
FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. It’s the…
Rise in chronic venous insufficiency procedures
The use of procedures to treat chronic venous insufficiency in Medicare patients increased markedly from 2005 through 2014, according to a study…
FDA approves hepatitis C drugs for pediatric patients
On April 7, the U.S. Food and Drug Administration (FDA) approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to…
FDA allows marketing of consumer genetic tests
On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health…
Yoga may ease side effects of prostate cancer treatment
For men with prostate cancer, structured yoga class twice a week during radiation treatment reduces fatigue and urinary and sexual dysfunction, according…